Image Credit: Canva Stock Photo Neurona Therapeutics has reached a major milestone in the development of its stem cell approach to treating epilepsy. A new phase in clinical trial The company recently announced that the first patient has been dosed in a Phase 1/2 clinical trial evaluating NRTX-1001, a cell therapy for adults whose epilepsy … Continue reading Neurona Doses First Patient in CIRM-Funded Bilateral Epilepsy Cell Therapy Trial
News
20 Years of CIRM: From building the infrastructure to clinical trials
Californians voted to support stem cell research 20 years ago. Now we’re building on what we’ve created through the California Institute for Regenerative Medicine (CIRM). Their initial $3 billion investment through Proposition 71 paved the way for voters to approve Proposition 14 in 2020. That added another $5.5 billion to advance the science. CIRM will … Continue reading 20 Years of CIRM: From building the infrastructure to clinical trials
CIRM awards $2.8 million to develop a gene therapy for rare neuromuscular disorders
Credit: Shutterstock The California Institute for Regenerative Medicine (CIRM) announced in January $100 million in funding for a broad range of projects, including four to support clinical programs. One of these was a $2.8 million award to Patricio Sepulveda, PhD, MBA, CEO of Amplo Biotechnology, Inc. That grant will support the development of a gene … Continue reading CIRM awards $2.8 million to develop a gene therapy for rare neuromuscular disorders
Honoring Dr. John Zaia: A Legacy of Science, Leadership, and Kindness
Photo Courtesy: City of Hope The scientific community lost a true pioneer with the passing of John A. Zaia, MD. Dr. Zaia was a visionary virologist, gene therapy trailblazer, and esteemed leader at City of Hope. He dedicated over four decades to advancing regenerative medicine. He left behind a profound impact on HIV research, pediatric … Continue reading Honoring Dr. John Zaia: A Legacy of Science, Leadership, and Kindness
Tackling Cell and Gene Therapy Manufacturing Challenges
CIRM Manufacturing Network Symposium attendees. The California Institute for Regenerative Medicine (CIRM) is driving conversations and collaboration to address the manufacturing challenges of cell and gene therapies (CGT). CIRM hosted its inaugural Manufacturing Network Symposium in South San Francisco, bringing together more than 100 experts and stakeholders from the regenerative medicine field, including scientific leaders … Continue reading Tackling Cell and Gene Therapy Manufacturing Challenges
The Stem Cellar’s Most Read Blogs of 2024
2024 was a significant year for the California Institute for Regenerative Medicine (CIRM). We reached major milestones, celebrated our 20th anniversary, and introduced our Strategic Allocation Framework (SAF) impact goals. We did this all while continuing to fund innovative work in regenerative medicine. The Stem Cellar blog is where we share these stories, providing readers … Continue reading The Stem Cellar’s Most Read Blogs of 2024
Two CIRM-funded research projects receive RMAT designation from FDA
The U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to two research projects funded by the California Institute for Regenerative Medicine (CIRM). RMAT is a fast‑track designation that speeds the development, review, and potential approval of treatments for serious or life‑threatening diseases. The first RMAT designation went to a … Continue reading Two CIRM-funded research projects receive RMAT designation from FDA
Remembering CIRM board member and ALS patient advocate Fred Fisher
CIRM honors the contributions of Fred Fisher, MSW, LCSW, a dedicated member of our Independent Citizens’ Oversight Committee (ICOC) and a passionate patient advocate. Fred passed away in September. He joined the ICOC as the ALS patient advocate in June 2021 and served in many roles, including co‑chair of the Standards Working Group and member … Continue reading Remembering CIRM board member and ALS patient advocate Fred Fisher
Celebrating Two Decades of Progress with CIRM’s 2024 Annual Report
Celebrate with us our two decades of progress. Our 2024 Annual Report highlights 20 years of advancing regenerative medicine. For twenty years, CIRM has pushed the boundaries of stem cell and gene therapy. We have funded more than 109 clinical trials and built the infrastructure that drives research and development. Our work has fueled innovation, … Continue reading Celebrating Two Decades of Progress with CIRM’s 2024 Annual Report
CIRM Welcomes New Board Members
The California Institute for Regenerative Medicine (CIRM) welcomes a distinguished group of new board members and alternates, each bringing a wealth of experience and leadership in healthcare, research, and innovation. Joyce A. Sackey, MD, FACP Dr. Sackey joins CIRM as an alternate for Linda Boxer. As the inaugural Chief Equity, Diversity, and Inclusion Officer at … Continue reading CIRM Welcomes New Board Members